Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARIAD PHARMACEUTICALS INC | 30,800 | reported | 07 Mar 2016 | tx 7+428,300−73,370 |
| Seres Therapeutics, Inc. | 7,954 | reported | 18 May 2026 | tx 72+2,410,951−316,960 |
| CUBIST PHARMACEUTICALS INC | 0 | reported | 21 Jan 2015 | tx 27+143,875−143,597 |
| GENZYME CORP | 0 | reported | 04 Apr 2011 | tx 31+100,243−253,685 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 244 | — | 10b5-1 |
| 18 May 2026 | SALE | Seres Therapeutics, Inc. | 79 | 7.53 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 133 | 0.00 USD | 10b5-1deriv |
| 15 May 2026 | EXERCISE | Seres Therapeutics, Inc. | 111 | 0.00 USD | 10b5-1deriv |
| 04 Mar 2026 | GRANT_AWARD | Seres Therapeutics, Inc. | 22,500 | 0.00 USD | deriv |
| 15 Feb 2026 | SALE | Seres Therapeutics, Inc. | 78 | 8.47 USD | |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 244 | — | |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 133 | 0.00 USD | deriv |
| 15 Feb 2026 | EXERCISE | Seres Therapeutics, Inc. | 111 | 0.00 USD | deriv |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 132 | — | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 112 | — | |
| 15 Nov 2025 | SALE | Seres Therapeutics, Inc. | 76 | 17.30 USD | |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 112 | 0.00 USD | deriv |
| 15 Nov 2025 | EXERCISE | Seres Therapeutics, Inc. | 132 | 0.00 USD | deriv |
| 18 Aug 2025 | SALE | Seres Therapeutics, Inc. | 76 | 16.65 USD | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 111 | — | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 133 | — | |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 111 | 0.00 USD | deriv |
| 15 Aug 2025 | EXERCISE | Seres Therapeutics, Inc. | 133 | 0.00 USD | deriv |
| 15 May 2025 | SALE | Seres Therapeutics, Inc. | 79 | 7.28 USD | |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 133 | — | |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 111 | — | |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 111 | 0.00 USD | deriv |
| 15 May 2025 | EXERCISE | Seres Therapeutics, Inc. | 133 | 0.00 USD | deriv |
| 18 Feb 2025 | SALE | Seres Therapeutics, Inc. | 4,300 | 0.81 USD |